Long term follow-up of the Intergroup Exemestane Study (IES)

PURPOSE: The Intergroup Exemestane Study (IES), an investigator-led study in 4724 postmenopausal patients with early breast cancer (ISRCTN11883920), has previously demonstrated that switching adjuvant endocrine therapy after 2-3 years tamoxifen to exemestane is associated with clinically relevant im...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Morden, James P, Alvarez, Isabel, Bertelli, Gianfilippo, Coates, Alan S, Coleman, Robert, Fallowfield, Lesley, Jassem, Jacek, Jones, Stephen, Kilburn, Lucy, Lønning, Per E., Ortmann, Olaf, Snowdon, Claire, van de Velde, Cornelis, Andersen, Jørn, Del Mastro, Lucia, Dodwell, David, Holmberg, Stig, Nicholas, Hanna, Paridaens, Robert, Bliss, Judith M, Coombes, R. Charles
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175047/
https://ncbi.nlm.nih.gov/pubmed/28467729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.70.5640
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars